Verve Ventures’ Post

Heading to this year's Eyecelerator @ AAO 2023? Meet #IDDI's CEO Linda Danielson and Shruti Jituri, PMP, Director of Business Development to discuss how we can leverage your upcoming ophthalmology drug or device development! See you there 👉 https://lnkd.in/dj-nvB8U #clinicalresearch #cro #ophthalmology #aao2023 #lifescience #trialdesign #biostatistics

Introducing Ep.2 of the Digital Dialogue Series! 🎉 This week join Mark Wuttke, CEO of Dopavision as he takes us through his Top 3 Reasons How Digital Can Transform Healthcare. Dopavision is deeply committed to revolutionizing the field of ophthalmology, particularly in addressing prevalent vision-related issues like myopia. Leveraging his pharma background he has been driving Dopavision to develop groundbreaking solutions that merge advanced research and innovative technology. Follow DTx Conference Series and see who Brandcast Health will interview next! #DTxEurope #DigitalTransformation #DigitalHealth #DigitalThereapeutics #DTx

I am passionate about UPSKILLING and RESKILLING opportunities as a successful global servant leader, lifelong learner, voracious reader, and world-class traveler with hands-on experience, business acumen, technological prowess, excellent skills sets and digital growth mindset. I look forward to joining a team of experts at the GCC Big Data and Cloud Computing Conference that will be held in May 2024 at Radisson Blu Hotel, in Kuwait. 1) What is the definition of an Organizational Human-centric Culture? How to Optimize Your Workforce's Well-being? How to maximize employee engagement with the right tools to thrive in dynamic environments? 2) How can organizations attract, hire, and retain the right TALENT and enhance their support by adopting a comprehensive benefits approach that addresses employees' needs at all stages of their journey? 3) How to build a Corporate Human-centric Culture of Trust, Mutual Respect and Collaboration that can foster an environment conducive to growth? 4) Is your organization at risk? How to assess organizational readiness and preparedness for digital transformation and AI technology management? 5) How to empower your talented teams to perform at their best?     

What's happening in the world of ophthalmology and clinical trials? Check out some of the insights from our team about top trends for the coming year and how to take advantage of them. With input from Jeanne Hecht, Julie Schlosser, Lanita Scott, M.D., and Andrew D. Pucker, OD, PhD, and Nicole Derthick. ______________________________________ #ophthalmology #clinicaltrials #lifesciences

Interested in biotech #entrepreneurship and don’t know where to begin? We have episodes for that! Our friend Karen Y. Torrejon, founder and CEO of Humonix Biosciences, Inc. is here at Association for Research in Vision and Ophthalmology (ARVO) (Booth #1344), and also is in your ears on “Bench to Boardroom” episode 4! https://lnkd.in/gi69arnK Listen, subscribe, come say hello, and learn!

Big news: We now raised a total of USD 15 million Series A funding to realize our vision of virtual care in urology 🎉 We are excited to announce that Kranus Health has secured $15M in Series A funding, co-led by SwissHealth Ventures, along with strong support from existing investors such as Karista, HTGF | High-Tech Gründerfonds, WENVEST Capital and A Round Capital. This funding will supercharge our mission to revolutionize digital therapies in urology through integrated care. 🌍 At Kranus Health, we're solving the challenge of limited access to effective urological treatments. Our integrated care approach, covering a range from andrology to uro-oncology, aims to make high-quality healthcare accessible to all. The new funds will help us expand globally, building on our success in France and beyond. 🏥 Our product lineup is growing too, addressing critical needs like erectile dysfunction and prostate enlargement. We've achieved incredible milestones over the past year, impacting thousands of patients and gaining recognition from urologists. 🙏 A big thank you to our dedicated team, investors, and partners who believe in reshaping urology care. Together, we're creating a healthier future. Onward and upward! 🙌🚀 #KranusHealth #SeriesAFunding #Urology #IntegratedCare #HealthcareInnovation

📌 1 month to go until World Sight Day!! World Sight Day is on Thursday, 12th October 2023, and this year International Agency for the Prevention of Blindness (IAPB) is focusing on the importance of eye care in the workplace with #LoveYourEyes at Work. Together, we can encourage employers to make eye health initiatives standard practice and promote eye health habits that will benefit the well-being, safety and productivity of millions of employees. Here are some things you can do to help: ✅ Prioritize your own eye health. Make sure to get regular eye exams and wear protective eyewear when needed. Don't forget to pledge your test at - Make A Pledge https://lnkd.in/dPVc_3Ap 👷♂️ Encourage your employer to provide quality eye care to employees. This could include providing on-site eye exams, vision insurance, or financial assistance for eyeglasses or contact lenses. 📢 Advocate for eye health awareness in your workplace. Talk to your colleagues and managers about the importance of eye care and how it can improve workplace safety and productivity. Together, we can make a difference in the fight against avoidable blindness. #WorldSightDay #LoveYourEyes Download workplace resources and find out how to host a workplace screening today from the IAPB website - www.iapb.org/WSD2023

We made a poster presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting.    The poster, entitled “VECTrans® technology: a powerful delivery approach to significantly enhance efficacy of therapeutic oligonucleotides in retina cells”, outlines a study assessing Vect-Horus’ proprietorial VECTrans® technology. This is based on the specific design and optimization of molecular vectors that, once joined to a payload, enable its delivery to target specific organs in the body.     The study showed that these vectors have the potential to improve delivery of medication to the eye. It’s a good demonstration of the technology’s potential, building further on our two recent major licensing agreements, with Novo Nordisk and Ionis Pharmaceuticals, Inc.     With thanks to Stéphane Girard, PhD, Ophthalmology Department Manager, and Sebastien Roux, PhD, Neuroscientist, for their work on this.    #biotech #vectors #drugdevelopment #breakingbarriers #opthalmology #arvo 

Data from PYC’s ongoing clinical trials in RP11 will be presented by Associate Professor Fred Chen of the Lions Eye Institute in a podium presentation on at the Association for Research in Vision and Ophthalmology (ARVO) conference in Seattle, Washington: https://buff.ly/4dps3CZ The presentation includes: – safety data from PYC’s ongoing dose escalation study demonstrating no treatment emergent serious adverse events across all three patient cohorts dosed to date; and – initial encouraging microperimetry data showing improvement in retinal sensitivity for one patient in cohort 3 (30 micrograms of the investigational drug candidate)

Unlock the secrets to successful ophthalmology clinical operations with First in Human: The Panel Series. Hear from leading experts on collaboration, protocol development, and overcoming trial challenges. Watch here: https://lnkd.in/d2Xh-8TZ